Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645948.RADVawPqzbSduI0nJ4lwmpeFkG-ijsYHJTm7f87ZrMw6M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645948.RADVawPqzbSduI0nJ4lwmpeFkG-ijsYHJTm7f87ZrMw6M130_assertion type Assertion NP645948.RADVawPqzbSduI0nJ4lwmpeFkG-ijsYHJTm7f87ZrMw6M130_head.
- NP645948.RADVawPqzbSduI0nJ4lwmpeFkG-ijsYHJTm7f87ZrMw6M130_assertion wasGeneratedBy ECO_0000203 NP645948.RADVawPqzbSduI0nJ4lwmpeFkG-ijsYHJTm7f87ZrMw6M130_provenance.
- NP645948.RADVawPqzbSduI0nJ4lwmpeFkG-ijsYHJTm7f87ZrMw6M130_assertion wasDerivedFrom befree-20150227 NP645948.RADVawPqzbSduI0nJ4lwmpeFkG-ijsYHJTm7f87ZrMw6M130_provenance.
- NP645948.RADVawPqzbSduI0nJ4lwmpeFkG-ijsYHJTm7f87ZrMw6M130_assertion SIO_000772 23406027 NP645948.RADVawPqzbSduI0nJ4lwmpeFkG-ijsYHJTm7f87ZrMw6M130_provenance.
- NP645948.RADVawPqzbSduI0nJ4lwmpeFkG-ijsYHJTm7f87ZrMw6M130_assertion evidence source_evidence_literature NP645948.RADVawPqzbSduI0nJ4lwmpeFkG-ijsYHJTm7f87ZrMw6M130_provenance.
- NP645948.RADVawPqzbSduI0nJ4lwmpeFkG-ijsYHJTm7f87ZrMw6M130_assertion description "[We conducted a study to determine whether the MAPK kinase (MEK) 1 and MEK2 inhibitor selumetinib (AZD6244, ARRY-142886) could reverse refractoriness to radioiodine in patients with metastatic thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645948.RADVawPqzbSduI0nJ4lwmpeFkG-ijsYHJTm7f87ZrMw6M130_provenance.